If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Trading Update

1 May 2013 07:00

RNS Number : 7043D
Renold PLC
01 May 2013
 



Renold plc

("Renold", "the Company" or "the Group")

 

Trading Update

 

Renold, a leading international supplier of industrial chains and related power transmission products, today issues a trading update ahead of its full year results for the year ended 31st March 2013, which will be announced on 28th May 2013.

 

Trading

Challenging conditions across all end markets persisted throughout the year and underlying revenue for the full year ended down 7% compared to the prior year. Group underlying second half revenue was 4% lower than the first half. The impact of the revenue reduction in the second half was fully offset by management action to reduce ongoing overheads. As a result, adjusted operating profit in the second half was in line with the first half and the full year adjusted operating profit is therefore in line with market expectations.

 

Working capital and debt

Working capital and capital expenditure were closely managed during the second half. This resulted in net cash generation in the second half, whilst at the year end net debt closed below the position at the start of the year.

 

During March, the Group agreed a new funding plan and merger of the UK defined benefit pension plans which is expected to reduce annual cash costs by £1.0m. In addition, since the year end, the Group completed the process of winding up the pension fund surplus in South Africa. A pre-tax cash surplus of £1.3m was returned to the Group in April 2013 with a further £0.1m outstanding.

 

Robert Purcell, Chief Executive of Renold plc, said:

"We are pleased with a good improvement in book to bill ratios in the second half versus the prior year. However, with trading conditions expected to remain challenging, we are developing plans to lower the Group's breakeven point and further improve our commercial position, and I look forward to reporting in further detail at the full year results announcement in May. The business remains focussed on delivering sustainable cash generation which has been enhanced by the recent progress on UK and South African pension schemes."

 

 

\* The use of "underlying" excludes the impact of changes in foreign exchange rates. "Adjusted" excludes the impact of exceptional items.

 

1 May 2013

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Arden Partners

020 7614 5917

Chris Hardie

College Hill

020 7457 2020

Mark Garraway

Helen Tarbet

 

  

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSEEFILIIV
Date   Source Headline
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return
18th May 202212:18 pmRNSPreference Stock Dividend
4th May 20227:00 amRNSAppointment of Non-Executive Director
19th Apr 20223:53 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update and Notice of Results
2nd Feb 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20229:23 amRNSHolding(s) in Company
20th Jan 20224:42 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202111:10 amRNSHolding(s) in Company
17th Dec 20218:43 amRNSBlock Listing Six Monthly Return
29th Nov 20213:15 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSInterim Results
8th Nov 20217:00 amRNSPreference Stock Dividend
5th Nov 20217:00 amRNSAppointment of Joint Broker
2nd Nov 202111:07 amRNSHolding(s) in Company
1st Nov 20211:04 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSNotice of Interim Results
20th Oct 20213:48 pmRNSHolding(s) in Company
31st Aug 202111:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.